These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14508205)

  • 21. High doses of lercanidipine are better tolerated than other dihydropyridines in hypertensive patients with metabolic syndrome: results from the TOLERANCE study.
    Barrios V; Escobar C; de la Figuera M; Honorato J; Llisterri JL; Segura J; Calderón A
    Int J Clin Pract; 2008 May; 62(5):723-8. PubMed ID: 18355238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renoprotective effect of calcium channel blockers in combination with an angiotensin receptor blocker in elderly patients with hypertension. A randomized crossover trial between benidipine and amlodipine.
    Miyagawa K; Dohi Y; Nakazawa A; Sugiura T; Yamashita S; Sato K; Kimura G
    Clin Exp Hypertens; 2010 Jan; 32(1):1-7. PubMed ID: 20144066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of pedal edema during treatment with S(-)-amlodipine nicotinate versus amlodipine besylate in female Korean patients with mild to moderate hypertension: a 12-week, multicenter, randomized, double-blind, active-controlled, phase IV clinical trial.
    Oh GC; Lee HY; Kang HJ; Zo JH; Choi DJ; Oh BH
    Clin Ther; 2012 Sep; 34(9):1940-7. PubMed ID: 22925988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
    Agrawal R; Marx A; Haller H
    J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ankle edema formation during treatment with the calcium channel blockers lacidipine and amlodipine: a single-centre study.
    Andrésdóttir MB; van Hamersvelt HW; van Helden MJ; van de Bosch WJ; Valk IM; Huysmans FT
    J Cardiovasc Pharmacol; 2000; 35(3 Suppl 1):S25-30. PubMed ID: 11347858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of aliskiren addition to amlodipine on ankle edema in hypertensive patients: a three-way crossover study.
    Fogari R; Zoppi A; Mugellini A; Maffioli P; Lazzari P; Monti C; Derosa G
    Expert Opin Pharmacother; 2011 Jun; 12(9):1351-8. PubMed ID: 21510830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G;
    Clin Ther; 2012 Aug; 34(8):1705-19. PubMed ID: 22853848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension.
    Tanaka T; Tsutamoto T; Sakai H; Fujii M; Yamamoto T; Horie M
    Hypertens Res; 2007 Aug; 30(8):691-7. PubMed ID: 17917316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lercanidipine valuable effect on urine protein losses: the RED LEVEL study.
    Robles NR; Calvo C; Sobrino J; Espinel E; Esteban R; Mateos L; Macias JF
    Curr Med Res Opin; 2016 Oct; 32(sup2):29-34. PubMed ID: 27779460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G;
    Clin Ther; 2012 Aug; 34(8):1720-34.e3. PubMed ID: 22853847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study.
    Kang SM; Youn JC; Chae SC; Park CG; Yang JY; Kim MH; Hong TJ; Kim CH; Kim JJ; Shin DG; Jeong JW; Yoon JH; Park SH; Kwon J; Cho SY
    Clin Ther; 2011 Dec; 33(12):1953-63. PubMed ID: 22136978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of amlodipine on 24-hour ambulatory blood pressure in hypertensive patients.
    Mroczek WJ; Burris JF; Allenby KS
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S13-5. PubMed ID: 16296699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 24-hour blood pressure control with the once-daily calcium antagonist amlodipine.
    Raftery EB; Heber ME; Brigden G; Al-Khawaja I
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S8-12. PubMed ID: 16296698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure.
    Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Fukuda T; Numao T; Shimada K; Kario K
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):394-400. PubMed ID: 17577104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium channel blockers, postural vasoconstriction and dependent oedema in essential hypertension.
    Pedrinelli R; Dell'Omo G; Mariani M
    J Hum Hypertens; 2001 Jul; 15(7):455-61. PubMed ID: 11464254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases.
    Kojima S; Shida M; Yokoyama H
    Hypertens Res; 2004 Jun; 27(6):379-85. PubMed ID: 15253102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study.
    Cheng KH; Cheng KC; Cheng KY; Yang YH; Lee CW; Lai WT
    Curr Med Res Opin; 2017 Jun; 33(6):1111-1117. PubMed ID: 28300435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.